{
    "clinical_study": {
        "@rank": "80744", 
        "acronym": "OptimEx-Clin", 
        "arm_group": [
            {
                "arm_group_label": "High Intensity Exercise", 
                "arm_group_type": "Experimental", 
                "description": "Patients perform interval- type endurance exercise at high intensity"
            }, 
            {
                "arm_group_label": "Moderate Continuous Exercise", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients perform endurance exercise at moderate intensity"
            }, 
            {
                "arm_group_label": "Usual Care", 
                "arm_group_type": "Sham Comparator", 
                "description": "Patients receive advice on being physically active as well as usual care"
            }
        ], 
        "brief_summary": {
            "textblock": "Aim of the clinical multicenter study (OptimEx-CLIN) is to assess the optimal exercise\n      intervention in patients with Heart Failure with preserved Ejection Fraction (HFpEF; also\n      termed diastolic heart failure) that will best improve peak oxygen uptake (Peak Vo2) and\n      additionally diastolic function (assessed echocardiographically). The investigators\n      hypothesize that exercise training reverses HFpEF and that intensity of exercise training is\n      more important than duration."
        }, 
        "brief_title": "Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure With Preserved Ejection Fraction", 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Heart Failure, Diastolic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Sedentary (structured exercise < 2x 30 min/wk)\n\n          -  At least 40 years old\n\n          -  Preserved systolic function LVEF > 50%\n\n          -  Signs and symptoms of heart failure class NYHA II or III\n\n          -  Diastolic dysfunction (E/\u00e9 > 15 or E/\u00e9 8-15 and NT-proBNP > 220 pg/ml)\n\n          -  Clinically stable for >= 6 weeks\n\n          -  Optimal medical treatment for >= 6 weeks\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Non- HFpEF causes for HF symptoms (significant valvular or coronary disease,\n             uncontrolled hypertension or arrhythmias, primary cardiomyopathies)\n\n          -  Significant pulmonary disease (FEV1 < 50% predicted, COPD GOLD III-IV)\n\n          -  Inability to exercise or conditions that may interfere with exercise intervention\n\n          -  Myocardial infarction in the previous three months\n\n          -  Signs of ischemia during exercise testing\n\n          -  Comorbidity that may influence one- year prognosis\n\n          -  Participation in another clinical trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078947", 
            "org_study_id": "EU 602405-2"
        }, 
        "intervention": [
            {
                "arm_group_label": "High Intensity Exercise", 
                "intervention_name": "High Intensity Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Moderate Continuous Exercise", 
                "intervention_name": "Moderate Continuous Exercise", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Usual Care", 
                "intervention_name": "Usual Care", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Diastolic heart failure, Heart failure with preserved ejection fraction, exercise", 
        "lastchanged_date": "May 30, 2014", 
        "link": {
            "url": "http://www.ntnu.edu/optimex"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Graz", 
                        "country": "Austria", 
                        "zip": "8036"
                    }, 
                    "name": "University Heart Center, Medical University Graz"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "2650"
                    }, 
                    "name": "Department of Cardiology, Antwerp University Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leipzig", 
                        "country": "Germany", 
                        "zip": "04289"
                    }, 
                    "name": "Klinik f\u00fcr Innere Medizin/ Kardiologie, Herzzentrum Leipzig- Universit\u00e4tsklinik"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Munich", 
                        "country": "Germany", 
                        "zip": "80992"
                    }, 
                    "name": "Department of Prevention, Rehabilitation and Sports Medicine, Technische Universit\u00e4t M\u00fcnchen"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Trondheim", 
                        "country": "Norway", 
                        "zip": "7491"
                    }, 
                    "name": "Department of Circulation and Medical Imaging, Norwegian University of Science and Technology"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Germany", 
                "Norway"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure- Clinical Study", 
        "overall_contact": {
            "email": "heinrich@sport.med.tum.de", 
            "last_name": "Christiane Heinrich, M.D.", 
            "phone": "+498928924446"
        }, 
        "overall_official": [
            {
                "affiliation": "Technische Universit\u00e4t M\u00fcnchen, Munich, Germany", 
                "last_name": "Martin Halle, M.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Technische Universit\u00e4t M\u00fcnchen, Munich, Germany", 
                "last_name": "Martin Halle, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Medical University Graz, Austria", 
                "last_name": "Burkert Pieske, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Antwerp University Hospital, Belgium", 
                "last_name": "Christiaan Vrints, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Heart Center Leipzig, Leipzig, Germany", 
                "last_name": "Volker Adams, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Norwegian University of Science and Technology, Trondheim, Norway", 
                "last_name": "Ulrik Wisl\u00f8ff, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Heart Center Leipzig, Leipzig, Germany", 
                "last_name": "Axel Linke, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commisson", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in Peak VO2 after three month intervention", 
            "measure": "Change in Peak VO2 after three months", 
            "safety_issue": "No", 
            "time_frame": "Baseline and three months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078947"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in E/e' (representing diastolic filling pressure) at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in E/e' at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in Peak VO2 at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in NTproBNP at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in NTproBNP at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Change in HRQOL as measured by the Kansas City Cardiomyopathy Questionnaire at baseline and three months", 
                "measure": "Change in health related quality of life at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "description": "Change in HRQOL as measured by the Kansas City Cardiomyopathy Questionnaire at baseline and 12 months", 
                "measure": "Change in health related Quality of life at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in Left Atrial Volume Index (LAVI) at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in Left Atrial Volume Index (LAVI) at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in e' medial at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in e' at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "submaximal exercise capacity will be measured using watts at the first ventilatory threshold (VT1)", 
                "measure": "Change in submaximal exercise capacity at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "description": "Submaximal exercise capacity will be measured using watts at the first ventilatory threshold (VT1)", 
                "measure": "Change in submaximal exercise capacity at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in VE/VCO2 slope at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in VE/VCO2 slope at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Change in Flow Mediated Dilation (FMD) at baseline and three months", 
                "safety_issue": "No", 
                "time_frame": "three months"
            }, 
            {
                "measure": "Change in Flow Mediated Dialation (FMD) at baseline and 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Technische Universit\u00e4t M\u00fcnchen", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Commission", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Leipzig", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital, Antwerp", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Medical University of Graz", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Norwegian University of Science and Technology", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t M\u00fcnchen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}